Jiangxi Fushine Pharmaceutical Co., Ltd.
SHZ: 300497.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jian Hua Bao
- Employees
- 1,963
- Headquarters
- Jingdezhen, China
- IPO year
- 2015
- Market cap
- CN¥9.9B
- Website
- https://www.fushine.cn
Loading 300497…
Loading profile data…Frequently asked questions about 300497
What does Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) do?
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as J...
Where does 300497.SZ trade?
Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300497.SZ in?
Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jiangxi Fushine Pharmaceutical Co., Ltd.?
Jian Hua Bao is the chief executive officer of Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ).
Where is Jiangxi Fushine Pharmaceutical Co., Ltd. headquartered?
Jiangxi Fushine Pharmaceutical Co., Ltd. is headquartered in China.
Does 300497.SZ pay a dividend?
Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300497.SZ go public?
Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) completed its initial public offering in 2015.